Survival Analysis of Surgically Resected ypN2 Lung Cancer after Neoadjuvant Therapy. Isgorucu O, Citak N. Thorac Cardiovasc Surg 2023;71:206-213.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Isgorucu O, Citak N. Survival Analysis of Surgically Resected ypN2 Lung Cancer after Neoadjuvant Therapy. Thorac Cardiovasc Surg 2023;71:206-213.
PMID: 35235990